Implementation of pharmacokinetic and pharmacodynamic strategies in early research phases of drug discovery and development at Novartis Institute of Biomedical Research

Tuntland, Tove, Ethell, Brian, Kosaka, Takatoshi, Blasco, Francesca, Zang, Richard Xu, Jain, Monish, Gould, Ty, Hoffmaster, Keith·2014·Frontiers in Pharmacology
DOI 10.3389/fphar.2014.00174

Cited by (242)

Items 201–242 of 242

  1. Diffuse Intrinsic Pontine Glioma: A multi-facetted and global view
    Sophie E. M. Veldhuijzen van Zanten · 2017 · Data Archiving and Networked Services (DANS)
  2. Brand innovator versus multisource cefpodoxime in respiratory tract infections: A comparative study
    JR Snyman, Constance Medlen · 2019 · South African Family Practice
  3. Measurement and mathematical modelling of endoplasmic reticulum stress in human adipocytes
    Alice M. Murphy · 2026 · Warwick Research Archive Portal (University of Warwick)
  4. Prologue: Cheminformatics and Its Applications
    Azhar Rasul · 2020 · IntechOpen eBooks
  5. Development of Molecularly Targeted Agents in Early Phase Clinical Trials
    Pedro Coelho Barata, Timothy Anthony Yap · 2020 · Springer eBooks
  6. 日記と物語の関係をめぐって : 『更級日記』を中心に
    守幸 伊藤 · 1992 · Institutional Repositories DataBase (IRDB)
  7. Professional Rational Drug and Biological Product Design Methods Based on Chemoinformatics as a Novel Science
    MM Ranjbar, SMH Banitaba, SH Mollazadeh, M H Motedayen, GH Karimi, M Helali Nasab · 2021 · Armaghane Danesh
  8. Mapping the Heterogeneous Distribution of Cancer Drugs by Imaging Mass Spectrometry
    Purva S. Damale, Shibdas Banerjee · 2022
  9. TRANSLATION AND VALIDATION OF MYELOID DERIVED SUPPRESSOR CELL PROTEOMIC TARGETS IN LIVER AND LUNG TUMORS
    Justin Trickett · 2022
  10. Predicting Dose and Selective Efficacy in Clinical Studies from Preclinical Experiments: Practical Pharmacodynamics
    Reginald Hill · 2017 · Royal Society of Chemistry eBooks
  11. Developing a hollow fiber infection model system to determine the PK/PD of conjugated oligoelectrolytes against clinically relevant pathogens
    Ruolan Wang · 2023
  12. Data from Pharmacokinetic/Pharmacodynamic Analysis of Savolitinib plus Osimertinib in an EGFR Mutation–Positive, MET-Amplified Non–Small Cell Lung Cancer Model
    Rhys D. O. Jones, Klas Petersson, Areya Tabatabai, Larry Bao, Helen K. Tomkinson, Alwin G. Schuller · 2023
  13. Data from Pharmacokinetic/Pharmacodynamic Analysis of Savolitinib plus Osimertinib in an EGFR Mutation–Positive, MET-Amplified Non–Small Cell Lung Cancer Model
    Rhys D. O. Jones, Klas Petersson, Areya Tabatabai, Larry Bao, Helen K. Tomkinson, Alwin G. Schuller · 2023
  14. Otimização de neolignanas como protótipos farmacêuticos para a leishmaniose visceral: mecanismo de ação e estudos farmacocinéticos
    Maiara Amaral de Oliveira · 2023
  15. Pharmacokinetics of Inhaled Medications – What Do We Know About Biological Macromolecules?
    Audrey Huili Lim, Jinxin Zhao, Nusaibah Abdul Rahim, Jing Zhao, Haiting Liu, Xiaoyan Yang, Yu-Wei Lin · 2023 · AAPS introductions in the pharmaceutical sciences
  16. Significance of Animals in Yoga and Meditation
    Pooja Nadholta, Vyas Shingatgeri · 2024 · Springer eBooks
  17. Antidiabetic Potentials of Catechin in Combination with Metformin: An In vitro and Molecular Docking Study
    Jyoshna Rani Dash, Gurudutta Pattnaik, Sovan Pattanaik, Goutam Ghosh, Goutam Rath, Biswakanth Kar · 2024 · Current Bioactive Compounds
  18. KRAS-driven cancer models for in vivo pharmacology and drug discovery
    Seema Chugh, Lukas E. Dow, Mallika Singh, Andrew J. Aguirre · 2024 · Elsevier eBooks
  19. Nonclinical safety assessment of vaccines: Up to date applications
    Nefise Ülkü Karabay Yavaşoğlu · 2024 · Ege Tıp Dergisi
  20. Advancing Pediatric Drug Safety: The Potential of Physiologically Based Pharmacokinetic Modeling
    Krishna Yadav · 2025 · Drug Metabolism and Bioanalysis Letters
  21. PKPD modeling and in silico models
    Rikard Pehrson, Susanne Winiwarter, Vigneshwari Subramanian, Mickael Mogemark, Filip N. Miljković · 2025 · Elsevier eBooks
  22. Identification of potential VP40 inhibitor of Marburg virus through molecular docking, pharmacokinetic analysis and molecular dynamics simulation
    Rohit Das, Anil Bhattarai, Buddhiman Tamang, Nagendra N. Thakur · 2025 · Scientific Reports
  23. Artificial Intelligence in Pharmaceutical Modelling
    Salah Abdalrazak Alshehade, Loh Wan Qi, Leong Qi Qi, Rachel Sam Rui Jun, Chong Pei Kee, Mohamad Dayoob, Haneen Alshehade, Ghazi A. Al Jabal, Sohail Aziz, Rofaida Alshehade · 2025 · Lecture notes in networks and systems
  24. Dose optimization of lymph node-targeted cyclosporine-A for lupus-driven vasculopathy
    Kabirat T Babalola, Raghu Ganugula, Meenakshi Arora, David Anderson, Sandeep Krishna Agarwal, Chandra Mohan, Babak Joseph Mehrara, Majeti N. V. Ravi Kumar · 2025 · Journal of Controlled Release
  25. Additional file 1 of New thiazole, thiophene and 2-pyridone compounds incorporating dimethylaniline moiety: synthesis, cytotoxicity, ADME and molecular docking studies
    Heba M. Metwally, Norhan M. Younis, Ehab Abdel‐Latif, Ali El‐Rayyes · 2024 · Figshare
  26. In silico Pharmacological and Toxicological Profiling of Lurasidone-related Substances, and their Impact on Lurasidone Safety
    Orwa Siddig, Mosab Yahya Al-Nour, Muhanad Elhafiz, Mohammed Ismail, Taijun Hang, Elsamoual Ibrahim Ahmedani, Amal A. Bahafi, Bashir Alsiddig Yousef · 2025 · Oriental Journal Of Chemistry
  27. Preclinical characterization of pharmacokinetics, enzyme occupancy, and pharmacodynamics of soticlestat (TAK-935), a novel cholesterol 24-hydroxylase inhibitor
    Maki Miyamoto, Toshiya Nishi, Tatsuki Koike, Shuhei Ikeda, Eiji Sunahara, Sayuri Watanabe, Shigeo Hasegawa, Tsuyoshi Ishii, Yohei Kosugi, Syunsuke Yamamoto et al. · 2026 · Journal of Pharmacology and Experimental Therapeutics
  28. Biomarkers in cancer pharmacology: Detection and monitoring of therapeutics
    Swikriti Sharma, Ritchu Babbar, Shriyansh Srivastava, Tapan Behl · 2026 · Elsevier eBooks
  29. Approaches to Drug Pharmacokinetics Study Design in Preclinical Trials (Review)
    Marina V. Karlina, Вера Михайловна Косман, M. N. Makarova, V. G. Makarov · 2026 · Ведомости Научного центра экспертизы средств медицинского применения
  30. Translational Quantitative Proteomic Assay for Bacteriophages: A New Frontier in Phage Pharmaceutical Development
    Thomas D. Nguyen, Connor E. Gould, Jacob T. Sanborn, Joshua Tutin, Yan Pan, Haoran Gao, Donna M. Ruszaj, Devin J. Angevine, Johnathan Bussa, Daniel Atakora et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Astragalus and Cordyceps Derivatives in the Treatment of Aging-Related Chronic Diseases and Neurodegenerative Disorders
    Kiran Reddy Kanubaddi, Chih-Liang Yaung, Horng‐Jyh Harn, Tzyy‐Wen Chiou, Shao-Xi Hsu, Ivan Wijaya, Shinn-Zong Lin, Wuli Wei · 2026 · International Journal of Molecular Sciences
  32. Integrative strategies in herbal product-based Drug discovery: from computational models to molecular insights
    Akhil Nair, Sinchana Suvarna, Shruthika Karkera, Anvitha Shettigar, M.K. Neenu, Swastika Maity, Vasudev Pai, Pavithra Pradeep Prabhu · 2026 · Beni-Suef University Journal of Basic and Applied Sciences
  33. An Open-Access Dialysis Membrane-Integrated Microfluidic Device for Generating Drug Exposure Profiles Through Molecular-Weight-Dependent Transport
    Hajime Miyashita, Kenta Shinha, Hiroko Nakamura, Moeno Kadoguchi, Hiroshi Arakawa, Hiroshi Kimura · 2026 · Micromachines
  34. Thymol as a natural monoterpenoid antibacterial agent: a comprehensive review of applications and current advances
    Serpil Uğraş, Pınar Göç Rasgele, Pınar Karagül, Nisa SİPAHİ, Halil İbrahim Uğraş · 2026 · Archives of Microbiology
  35. Simultaneous determination and ADME profiling of betulinic and ursolic acids from Avicennia marina in Wistar rats
    Mayuresh Joshi, Sunita Shailajan, Sasikumar Menon - · 2026 · Discover Pharmaceutical Sciences
  36. Inhibitors for a conserved filarial catechol-O-methyltransferase with potent efficacy against all life-stages of Brugia malayi infection in gerbils
    Md. Mukthar Mia, Md Fulbabu Sk, Bhesh Paudel, Abdur Azam, Idrees Mehraj Allaie, Xuejin Zhang, Emad Tajkhorshid, William Harold Witola · 2026 · Scientific Reports
  37. Useful tools for artificial intelligence-based development of nanomedicine and precision pharmaceuticals: smart solutions for future therapeutics
    Z. Rostami, Parnia Aftabi, Seyed Mohammad Ayyoubzadeh, Rosa Negahdari, Maryam Kazemi, Reyhane Masoudifar, Niloofar Masoumi, Mahnaz Ahmadi, Niki Pouyanfar, Fatemeh Ghorbani-Bidkorpeh · 2026 · Results in Engineering
  38. Prediction of Plasma Concentration−Time Profiles in Mice from Chemical Structure Using a Kinetically Constrained Hybrid Neural ODE
    Yuki Doi, Harutoshi Kato, Fumiyoshi Yamashita · 2026 · Molecular Pharmaceutics
  39. BindingDB Entry 50009811: Use of Osmotic Pumps to Establish the Pharmacokinetic-Pharmacodynamic Relationship and Define Desirable Human Performance Characteristics for Aggrecanase Inhibitors.
    BindingDB · 2021 · UC San Diego
  40. BindingDB Entry 50014670: Discovery of IACS-9779 and IACS-70465 as Potent Inhibitors Targeting Indoleamine 2,3-Dioxygenase 1 (IDO1) Apoenzyme.
    BindingDB · 2022 · UC San Diego
  41. BindingDB Entry 50018226: The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules.
    BindingDB · 2024 · UC San Diego
  42. Functional Food to Therapeutic Lead: Structure‐Based Molecular Docking and Simulation Reveal Anti‐Inflammatory Potential of Toddy ‐Derived Metabolites Targeting SerpinB4
    Souvik Das, Rohit Das, Anil Kumar Verma, Buddhiman Tamang, Jyoti Prakash Tamang · 2026 · ChemistrySelect